Trial NCT07112287
Germline Testing for Predisposition to Myeloid Malignancies
- Phase
- Not given
- Sponsor
- Christopher Reilly
- Conditions
- Myeloid Malignancy; Genetic Predisposition to Disease; Myeloid Hematological Malignancies
- Ages
- 18+ years
Eligibility criteria
Highlighted: restrictions our model extracted, each a verbatim quote (pink = excludes outright, blue = only under conditions).
Inclusion Criteria:
* Age of 18 years or older
* Participants must have histologically confirmed myeloid malignancy OR bone marrow failure within the last 6 months prior to screening.
* Ability to understand and provide a signed and completed consent document in English.Language
Exclusion Criteria:
* Participants who cannot safely undergo clinically indicated skin biopsy as adjudicated by the study team.
* Participants who have previously undergone germline genetic testing for predisposition to myeloid malignancies
Restrictions found (1)
- LanguageOutrightinclusionShow in the text
Recruiting in Massachusetts
- Dana-Farber Cancer Institute · Boston, Suffolk County